Brief: Biocept Reports Second Quarter 2021 Financial Results
Aug 16 (Reuters) - Biocept Inc BIOC.O :
* BIOCEPT REPORTS SECOND QUARTER 2021 FINANCIAL RESULTS
* BIOCEPT INC - Q2 REVENUES OF $12.0 MILLION DRIVEN BY
RT-PCR
COVID-19 TESTING
* BIOCEPT INC QTRLY LOSS PER SHARE $0.14
* BIOCEPT INC - REPORTED CASH AND CASH EQUIVALENTS AS OF
JUNE 30,
2021 OF $19.5 MILLION
Source text for Eikon: ID:nBw5lZWsa
Further company coverage: BIOC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biocept
See all newsBrief: Biocept Says Trading Of Common Stock Will Be Suspended By Nasdaq At Opening Of Business On Oct 25
U.S. STOCKS ON THE MOVE-Overstock.com, Biocept, Birkenstock
Biocept slumps after filing for bankruptcy protection
Brief: Biocept CEO Antonino Morales Resigns
U.S. STOCKS ON THE MOVE-Albemarle, Novavax, WeWork